news and events

سمينار. دو روزه ميوپاتي ها و بيماري هاي Neuromuscular junction

سمينار دو روزه بيماريهاي عضلاني و نوروماسكولار جانكشن با دعوت اساتيد مدعو از فرانسه و اساتيد برجسته ايراني بيمارستان شريعتي٢٥-٢٦ آذرماه ٩٥

First Iranian consensus on use of vitamin D in patients with multiple sclerosis published in BMC Neurology

Accumulating evidences from experimental, epidemiologic and clinical studies support the potential linkage between poor vitamin D status and the risk of developing Multiple Sclerosis (MS), as well as, an adverse disease course. However, the results of the trials on the clinical outcomes of vitamin D supplementation in MS patients are less consistent which brought many discrepancies in routine practice. In this article we presented a summary of a symposium on vitamin D and MS.

Ninety percent of stroke burden can be avoided

New research looking at the risk factors contributing to stroke burden — the number of healthy life-years lost due to stroke — has shown that behavioral factors play a larger role than metabolic factors."Poor diet, smoking, alcohol, lack of exercise, et cetera, are responsible for more days of stroke disability than factors such as hypertension, hyperglycemia, high cholesterol, et cetera. Our data show that stroke is definitely a disease of lifestyle, and as such a great proportion of stroke disability can be avoided.

Education Articles

Amir Babak Ghaemmaghami, MD 
Neurologist
One of the challenges facing behaviorally orientedneurologists is that many patients' symptoms fallbeyond the scope of a physical neurological evaluation.Frequently, patients with neurodegenerative disease,particularly in the early stages, present with intactcranial nerves, reflexes, eye movements, and sensory-motor function. Accordingly, clinicians need tools to formally assess the cognitive, psychiatric and behavioral abnormalities that define many dementing disorders.
 

An estimated 1.2 million visits to US emergency departments for acute migraine take place every year.

Accumulating evidences from experimental, epidemiologic and clinical studies support the potential linkage between poor vitamin D status and the risk of developing Multiple Sclerosis (MS), as well as, an adverse disease course.